Italia markets closed

BMY Nov 2025 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,99000,0000 (0,00%)
Alla chiusura: 03:39PM EDT
Schermo intero
Chiusura precedente1,9900
Aperto1,8900
Denaro1,6900
Lettera1,9400
Prezzo d'esercizio35,00
Scadenza2025-11-21
Min-Max giorno1,8900 - 1,9900
Contratto - Min-MaxN/D
Volume32
Open Interest202
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri